A-Care S Tablet 10 mg (Solifenacin Succinate)

Adult dose

The usual recommended dose for adults (including older adults) is 5mg once daily. If necessary, the dose may be increased to a maximum of 10mg once daily. This medicine may be taken without regard to meals and should be swallowed whole with water. Dosage adjustment is required for the following patients. 1. Patients with renal impairment No dose adjustment is necessary for patients with mild or moderate renal impairment (creatinine clearance>30ml/min). Use with caution in patients with severe renal impairment (creatinine clearance≤30ml/min), and do not exceed 5mg once daily. 2. Patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment. Use with caution in patients with moderate hepatic impairment (Child-Pugh class B), and do not exceed 5mg once daily. 3. Patients taking potent cytochrome P450 3A4 (CYP3A4) inhibitors Limit the maximum daily dose to 5mg in patients taking ketoconazole or other potent CYP3A4 inhibitors (e.g., ritonavir, nelfinavir, itraconazole).

This drug should not be used in patients with certain diseases or conditions. Patients with obstructed urinary tract or difficulty urinating, patients with severe gastrointestinal diseases, patients with myasthenia gravis, patients with glaucoma, patients with allergies to this drug or its ingredients, patients undergoing dialysis, and patients with severely impaired liver or kidney function should not be administered this drug. Additionally, patients with genetic disorders like lactose intolerance should also avoid this medication. This drug should be used with caution in patients at risk of urinary obstruction or decreased gastrointestinal motility, patients with severe kidney or liver dysfunction, and patients taking certain potent medications. Using this drug may cause symptoms such as dry mouth, constipation, blurred vision, and in rare cases, difficulty urinating, vascular edema, and allergic reactions. Caution should be taken when driving or operating machinery during the use of this drug, and dose adjustment may be necessary when used with other anticholinergic drugs or medications that inhibit specific liver metabolic enzymes due to potential drug interactions. Pregnant women and nursing mothers should use this drug with caution, and it should not be used in children as safety and efficacy have not been established.

• Dry mouth
• constipation
• blurred vision
• urinary retention
• dry eyes
• nausea
• dyspepsia
• upper abdominal pain
• vomiting
• urinary tract infection

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature of 1 to 30 degrees Celsius room temperature. This will help to safely maintain the drug's efficacy.

Appearance

Pale pink round film-coated tablet

Package unit

100 tablets/box [10 tablets/PTP*10]